naringenin and Hepatocellular Carcinoma

naringenin has been researched along with Hepatocellular Carcinoma in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (46.15)29.6817
2010's5 (38.46)24.3611
2020's2 (15.38)2.80

Authors

AuthorsStudies
Jia, Y; Liu, J; Pan, X; Ren, X; Xia, X; Xu, Z; Yang, X1
Badria, F; El Saadany, AA; Elnawasany, S; Haggag, YA; Ibrahim, MAA; Shalaby, SM; Soliman, NA1
Abdulaal, WH; ALbukhari, A; Bawazeer, NA; Choudary, H; Middleton, B; Moselhy, SS; Zamzami, MA; Zeyadi, M1
Cao, F; Cao, P; Cheng, Y; He, Y; Jia, B; Meng, X; Wang, Y; Yang, C; Yu, D; Yu, G1
Arul, D; Subramanian, P2
Liu, CJ; Yeh, CC; Yen, HR1
Borradaile, NM; de Dreu, LE; Huff, MW1
Han, EH; Jeong, HG; Jeong, TC; Kim, JY; Lee, ES; Shin, DW; Woo, ER1
Gairola, CG; Puppala, D; Swanson, HI1
Fukuda, S; Kojiro, M; Nakashima, O; Ookawa, K; Sakata, Y; Suto, K; Takahata, T; Tamura, Y; Tanaka, M; Tateishi, T; Yano, H1
Casali, M; Chung, RT; Goldwasser, J; Nahmias, Y; van Poll, D; Wakita, T; Yarmush, ML1
Borradaile, NM; de Dreu, LE; Huff, MW; Wilcox, LJ1

Other Studies

13 other study(ies) available for naringenin and Hepatocellular Carcinoma

ArticleYear
Naringenin and Quercetin Exert Contradictory Cytoprotective and Cytotoxic Effects on Tamoxifen-Induced Apoptosis in HepG2 Cells.
    Nutrients, 2022, Dec-19, Volume: 14, Issue:24

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Hep G2 Cells; Humans; Quercetin; Reactive Oxygen Species; Tamoxifen

2022
Anti-cancer effect of nano-encapsulated boswellic acids, curcumin and naringenin against HepG-2 cell line.
    BMC complementary medicine and therapies, 2023, Jul-29, Volume: 23, Issue:1

    Topics: Carcinoma, Hepatocellular; Cell Line; Curcumin; Humans

2023
POSSIBLE REGULATION OF LDL-RECEPTOR BY NARINGENIN IN HEPG2 HEPATOMA CELL LINE.
    African journal of traditional, complementary, and alternative medicines : AJTCAM, 2017, Volume: 14, Issue:1

    Topics: Carcinoma, Hepatocellular; Flavanones; Gene Expression Regulation; Hep G2 Cells; Humans; Liver Neoplasms; Phosphatidylinositol 3-Kinases; Receptors, LDL; Sterol Regulatory Element Binding Protein 1; Sterol Regulatory Element Binding Protein 2

2017
Naringenin ameliorates insulin resistance by modulating endoplasmic reticulum stress in hepatitis C virus-infected liver.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 115

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Endoplasmic Reticulum Stress; Endoribonucleases; Flavanones; Gene Expression Regulation; Hepacivirus; Hepatitis C; Humans; Insulin Resistance; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Protein Serine-Threonine Kinases

2019
Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells.
    Pathology oncology research : POR, 2013, Volume: 19, Issue:4

    Topics: Analysis of Variance; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Growth Processes; Flavanones; Hep G2 Cells; Humans; Liver Neoplasms

2013
Naringenin suppresses TPA-induced tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells.
    Chemico-biological interactions, 2015, Jun-25, Volume: 235

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Movement; Flavanones; Hep G2 Cells; Humans; I-kappa B Proteins; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Mice; Neoplasm Invasiveness; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphorylation; Signal Transduction; Tetradecanoylphorbol Acetate; Transcription Factor AP-1

2015
Attenuation of NDEA-induced hepatocarcinogenesis by naringenin in rats.
    Cell biochemistry and function, 2013, Volume: 31, Issue:6

    Topics: Animals; Apoptosis; Carcinogenesis; Carcinoma, Hepatocellular; Cell Proliferation; Down-Regulation; Flavanones; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Nitrosamines; Rats; Up-Regulation

2013
Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation.
    Diabetes, 2003, Volume: 52, Issue:10

    Topics: Animals; Apolipoproteins B; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; DNA-Binding Proteins; Enzyme Activation; Fatty Acids; Flavanones; Humans; Insulin Receptor Substrate Proteins; Liver Neoplasms; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Receptors, LDL; Sterol Regulatory Element Binding Protein 1; Transcription Factors; Triglycerides; Tyrosine

2003
Suppression of CYP1A1 expression by naringenin in murine Hepa-1c1c7 cells.
    Archives of pharmacal research, 2004, Volume: 27, Issue:8

    Topics: Animals; Carcinoma, Hepatocellular; Cytochrome P-450 CYP1A1; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavanones; Gene Expression Regulation, Enzymologic; Liver Neoplasms; Mice

2004
Identification of kaempferol as an inhibitor of cigarette smoke-induced activation of the aryl hydrocarbon receptor and cell transformation.
    Carcinogenesis, 2007, Volume: 28, Issue:3

    Topics: Anticarcinogenic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Transformation, Neoplastic; Dimethyl Sulfoxide; Flavanones; Flavones; Flavonoids; Humans; Kaempferols; Liver Transplantation; Luteolin; Receptors, Aryl Hydrocarbon; Resveratrol; Smoking; Stilbenes

2007
Chemosensitivity determinants of irinotecan hydrochloride in hepatocellular carcinoma cell lines.
    Basic & clinical pharmacology & toxicology, 2008, Volume: 102, Issue:4

    Topics: Acridines; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Camptothecin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Flavanones; Gene Expression Regulation, Neoplastic; Glucuronosyltransferase; Humans; Inhibitory Concentration 50; Irinotecan; Liver Neoplasms; Neoplasm Proteins; RNA, Messenger; Tetrahydroisoquinolines; Transfection

2008
Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin.
    Hepatology (Baltimore, Md.), 2008, Volume: 47, Issue:5

    Topics: Apolipoproteins B; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Citrus paradisi; DNA Primers; Enzyme-Linked Immunosorbent Assay; Flavanones; Gene Silencing; Hepacivirus; Humans; Liver Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Viral Core Proteins

2008
Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP.
    Journal of lipid research, 2001, Volume: 42, Issue:5

    Topics: Anticholesteremic Agents; Apolipoproteins B; Carcinoma, Hepatocellular; Carrier Proteins; Cholesterol; Cholesterol Esters; Citrus; Enzyme-Linked Immunosorbent Assay; Flavanones; Flavonoids; Hepatocytes; Hesperidin; Humans; Receptors, LDL; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2; Triglycerides; Tumor Cells, Cultured

2001